TrialPanorama/TrialPanorama-database huggingface dataset:
Study 25884010 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 25884010 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 11399215 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 3435119 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 25127725 — Surrogate Endpoint (SUR): Blood pressure
Study 24369254 — Monitoring Biomarker (MOI): HBV DNA
Study 14527092 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 10920066 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 3993553 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 3993553 — Surrogate Endpoint (SUR): Blood pressure
Study 18774469 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 10660867 — Surrogate Endpoint (SUR): Blood pressure
Study 31663833 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 31053510 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 22836707 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 22836707 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22836707 — Surrogate Endpoint (SUR): Blood pressure
Study 8789545 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 8789545 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 8789545 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 8789545 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 15829326 — Predictive Biomarker (PRD): ASRGL1 mRNA
Genes: ASRGL1; ALP; CRASH
Study 15858936 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 30192210 — Surrogate Endpoint (SUR): Blood pressure
Study 23540718 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 25869603 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 20716911 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15231367 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22231921 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study 9860036 — Safety Biomarker (SAF): Interleukin 1
Study 8589159 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 31510721 — Predictive Biomarker (PRD): PCSK5 mRNA
Genes: PCSK5; PC5; PC6
Study 25890480 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 19414675 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 19414675 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 29793869 — Surrogate Endpoint (SUR): Blood pressure
Study 28295143 — Surrogate Endpoint (SUR): Blood pressure
Study 26252749 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 23718900 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study 23718900 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 22575988 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 16541481 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28455318 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 24321183 — Safety Biomarker (SAF): Pentraxin-related protein PTX3
Genes: PTX3; TNFAIP5; TSG14
Study 24321183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24321183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24321183 — Surrogate Endpoint (SUR): Serum creatinine
Study 2459543 — Surrogate Endpoint (SUR): Blood pressure
Study 15784645 — Surrogate Endpoint (SUR): Blood pressure
Study 27053195 — Surrogate Endpoint (SUR): Blood pressure
Study 9241285 — Surrogate Endpoint (SUR): Blood pressure
Study 26763851 — Surrogate Endpoint (SUR): Blood pressure
Study 12574563 — Surrogate Endpoint (SUR): Blood pressure
Study 21084403 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21084403 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 17289894 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 14563654 — Surrogate Endpoint (SUR): Bone mineral density
Study 24216034 — Surrogate Endpoint (SUR): Bone mineral density
Study 17694391 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 15774238 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9801994 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 31938726 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 31938726 — Safety Biomarker (SAF): BDNF
Study 30037817 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 30037817 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 19942995 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 14722206 — Predictive Biomarker (PRD): ITGAM mRNA
Genes: ITGAM; CD11B; CR3A
Study 14722206 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study 14722206 — Predictive Biomarker (PRD): LTB mRNA
Genes: LTB; TNFC; TNFSF3
Study 21106086 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29703335 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 29703335 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 22229650 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20550223 — Predictive Biomarker (PRD): TOX mRNA
Genes: TOX; KIAA0808
Study 20550223 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study 20234301 — Surrogate Endpoint (SUR): Blood pressure
Study 20234301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19029270 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 19029270 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 12207568 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12207568 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8670315 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8670315 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 6135076 — Surrogate Endpoint (SUR): Serum calcium
Study 22130425 — Predictive Biomarker (PRD): CD63 mRNA
Genes: CD63; MLA1; TSPAN30
Study 17646413 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 17646413 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 12409716 — Predictive Biomarker (PRD): CPA1 mRNA
Genes: CPA1; CPA
Study 7633141 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 3720570 — Surrogate Endpoint (SUR): Blood pressure
Study 19931756 — Predictive Biomarker (PRD): HYLS1 mRNA
Genes: HYLS1; HLS
Study 30773798 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30773798 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 30773798 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 30773798 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 30773798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26833624 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 29567399 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 22781309 — Surrogate Endpoint (SUR): Blood pressure
Study 16542392 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16542392 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 16542392 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 11910595 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 1783919 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study 25545238 — Surrogate Endpoint (SUR): Blood pressure
Study 15048065 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 9149578 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 31697272 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31697272 — Surrogate Endpoint (SUR): Blood pressure
Study 25937633 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 23513399 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 15523294 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 22184381 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 22184381 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 17967221 — Surrogate Endpoint (SUR): Bone mineral density
Study 2373136 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 2373136 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 29460712 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 29460712 — Safety Biomarker (SAF): BDNF
Study 23883377 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 19650752 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 11368732 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 27715368 — Predictive Biomarker (PRD): RIT1 mRNA
Genes: RIT1; RIBB; RIT; ROC1
Study 21123186 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 30609411 — Predictive Biomarker (PRD): HPSE mRNA
Genes: HPSE; HEP; HPA; HPA1; HPR1; HPSE1; HSE1
Study 24123098 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22958580 — Predictive Biomarker (PRD): LSR mRNA
Genes: LSR; ILDR3; LISCH
Study 16307219 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 16307219 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study 16307219 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 19390752 — Predictive Biomarker (PRD): TNFR1B
Genes: TNFRSF1B; TNFBR; TNFR80; TNF-R75; TNF-R-II; p75; CD120b
Study 11446724 — Surrogate Endpoint (SUR): Blood pressure
Study 28183047 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 28183047 — Predictive Biomarker (PRD): CD44 mRNA
Genes: CD44; LHR; MDU2; MDU3; MIC4
Study 28183047 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study 28183047 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 28183047 — Predictive Biomarker (PRD): CASP3 mRNA
Genes: CASP3; CPP32
Study 28183047 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 28183047 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 12065339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7648772 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 7648772 — Surrogate Endpoint (SUR): Blood pressure
Study 30355322 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 22205311 — Surrogate Endpoint (SUR): Blood pressure
Study 15795448 — Surrogate Endpoint (SUR): Bone mineral density
Study 31171876 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28794054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28794054 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 28794054 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 23514874 — Safety Biomarker (SAF): IL-6 and IL-10
Study 21199979 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 16004778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16004778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16004778 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 2681508 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 2681508 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28410617 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24069844 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 19699861 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 27199121 — Surrogate Endpoint (SUR): Blood pressure
Study 25701829 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 18193385 — Surrogate Endpoint (SUR): Serum creatinine
Study 17106142 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12612168 — Surrogate Endpoint (SUR): Bone mineral density
Study 1600852 — Surrogate Endpoint (SUR): Blood pressure
Study 1600852 — Surrogate Endpoint (SUR): Serum hemoglobin A1C
Study 1600852 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 22456954 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22456954 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 15823640 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15823640 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 10381769 — Surrogate Endpoint (SUR): Blood pressure
Study 9345413 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28853210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28853210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17330681 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28648618 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 16372588 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12225725 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10436103 — Surrogate Endpoint (SUR): Blood pressure
Study 7573844 — Surrogate Endpoint (SUR): Blood pressure
Study 31117236 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 26545369 — Safety Biomarker (SAF): Interleukin 1
Study 26545369 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 21140269 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 17016059 — Surrogate Endpoint (SUR): Blood pressure
Study 30321318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26023212 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17897270 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17897270 — Surrogate Endpoint (SUR): Blood pressure
Study 11912385 — Surrogate Endpoint (SUR): Serum testosterone
Study 2128988 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 2128988 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 29235560 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 29235560 — Surrogate Endpoint (SUR): Blood pressure
Study 29235560 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 21029013 — Surrogate Endpoint (SUR): Blood pressure
Study 28379325 — Surrogate Endpoint (SUR): Bone mineral density
Study 15249716 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 7813219 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 7813219 — Predictive Biomarker (PRD): SERPINA6 mRNA
Genes: SERPINA6; CBG
Study 6319152 — Surrogate Endpoint (SUR): Blood pressure
Study 14763918 — Surrogate Endpoint (SUR): Blood pressure
Study 14763918 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 14763918 — Surrogate Endpoint (SUR): Serum triglycerides
Study 11346729 — Surrogate Endpoint (SUR): Blood pressure
Study 28821519 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 31161692 — Surrogate Endpoint (SUR): Blood pressure
Study 19828561 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 15716196 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29378197 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study 24153001 — Surrogate Endpoint (SUR): Blood pressure
Study 16707980 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 25151339 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 28600466 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 15159322 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 15159322 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 9726695 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9726695 — Surrogate Endpoint (SUR): Blood pressure
Study 22978318 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 19041041 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 8858671 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 17431604 — Surrogate Endpoint (SUR): Urinary oxalate
Study 22826271 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 22826271 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 29972759 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 29972759 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study 29972759 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 24382782 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 21993078 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 9708644 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 9708644 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 7893440 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 30540337 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 30540337 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26923543 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 26061330 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 18789762 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18789762 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 15231443 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 15641767 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 363334 — Surrogate Endpoint (SUR): Blood pressure
Study 363334 — Surrogate Endpoint (SUR): Serum potassium
Study 20032538 — Monitoring Biomarker (MOI): HBV DNA
Study 21365405 — Surrogate Endpoint (SUR): Blood pressure
Study 18440341 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 8960574 — Predictive Biomarker (PRD): CAST mRNA
Genes: CAST
Study 1413942 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 27887597 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 9388311 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 9388311 — Predictive Biomarker (PRD): PPA1 mRNA
Genes: PPA1; IOPPP; PP
Study 31099300 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 31099300 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 31099300 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 27077879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27077879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 27077879 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24622117 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 24622117 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 24622117 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22914404 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 16001233 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study 27927683 — Surrogate Endpoint (SUR): Blood pressure
Study 25765698 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23340440 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 23340440 — Safety Biomarker (SAF): Hyaluronic acid
Study 19386741 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 23855301 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 17467914 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17467914 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 15179174 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 7872714 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 3337013 — Surrogate Endpoint (SUR): Blood pressure
Study 3337013 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 15917194 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 12789036 — Surrogate Endpoint (SUR): Blood pressure